Program Development Center, Center of Expertise for Chronic Organ Failure (CIRO+), Horn, The Netherlands; Centro de Pesquisa em Ciências da Saúde, Centro de Ciências Biológicas e da Saúde, Universidade Norte do Paraná (UNOPAR), Londrina, Paraná, Brazil; Laboratório de Pesquisa em Fisioterapia Pulmonar, Departamento de Fisioterapia, Universidade Estadual de Londrina (UEL), Londrina, Paraná, Brazil.
Arch Phys Med Rehabil. 2013 Nov;94(11):2131-8. doi: 10.1016/j.apmr.2013.03.024. Epub 2013 Apr 10.
To investigate the within-day test-retest reliability of the Timed Up & Go (TUG) test in patients with advanced chronic obstructive pulmonary disease (COPD), chronic heart failure (CHF), and chronic renal failure (CRF).
Cross-sectional.
Patients' home environment.
Subjects (N=235, 64% men; median age, 70y [interquartile range, 61-77y]; median body mass index, 25.6kg/m(2) [interquartile range, 22.8-29.4kg/m(2)]) with advanced COPD (n=95), CHF (n=68), or CRF (n=72).
Not applicable.
Time to complete the TUG test. Three trials were performed on the same day and by the same assessors. The intraclass correlation coefficient (ICC), kappa coefficient, standard error of measurement, and absolute and relative minimal detectable change (MDC) values were calculated.
Good agreement was observed, in general, for both the total sample and subgroups (COPD, CHF, CRF), with ICC values ranging from .85 to .98, and kappa coefficients from .49 to 1.00. However, statistical improvement occurred in the total sample from the first to the second trial with large limits of agreement (mean difference, -.97s; 95% confidence interval, 3.00 to -4.94s; P<.01). The third trial added little or no information to the first 2 trials. For the total sample, a standard error of measurement value of approximately 1.6 seconds, an absolute value of MDC at the 95% confidence level (MDC95%) of approximately 4.5 seconds, and a relative value of MDC at the 95% confidence level (MDC95%%) of approximately 35% were found between the first 2 trials, with similar values found for the subgroups.
The TUG test is reliable in patients with advanced COPD, CHF, or CRF after 2 trials. Values of standard error of measurement and MDC may be used in daily clinical practice with these populations to define what is expected and what represents true change in repeated measures.
研究 Timed Up & Go(TUG)测试在晚期慢性阻塞性肺疾病(COPD)、慢性心力衰竭(CHF)和慢性肾衰竭(CRF)患者中的日内重测信度。
横断面研究。
患者的家庭环境。
受试者(N=235,64%为男性;中位年龄 70 岁[四分位间距 61-77 岁];中位体重指数 25.6kg/m2[四分位间距 22.8-29.4kg/m2]),包括晚期 COPD 患者 95 例、CHF 患者 68 例和 CRF 患者 72 例。
无。
完成 TUG 测试的时间。由同一位评估者在同一天内进行 3 次测试。计算组内相关系数(ICC)、kappa 系数、测量误差的标准误差以及绝对和相对最小可检测变化值(MDC)。
总体而言,对于全样本和亚组(COPD、CHF、CRF),观察到良好的一致性,ICC 值范围为.85 至.98,kappa 值范围为.49 至 1.00。然而,与第 1 次试验相比,第 2 次试验的总样本的统计数据有所改善,且一致性界限较大(平均差异,-0.97s;95%置信区间,3.00 至-4.94s;P<.01)。第 3 次试验对前 2 次试验的信息增加很少或没有增加。对于全样本,第 1 次和第 2 次试验的测量误差标准误差值约为 1.6 秒,95%置信区间的绝对 MDC 值(MDC95%)约为 4.5 秒,95%置信区间的相对 MDC 值(MDC95%)约为 35%。亚组也得到了类似的结果。
TUG 测试在晚期 COPD、CHF 或 CRF 患者中进行 2 次试验后具有可靠性。在这些人群中,可使用测量误差标准值和 MDC 值来确定日常临床实践中的预期值和真正的重复测量变化值。